Provided by Tiger Trade Technology Pte. Ltd.

Black Diamond Therapeutics, Inc.

2.14
+0.10004.90%
Post-market: 2.150.0101+0.47%19:30 EDT
Volume:561.28K
Turnover:1.18M
Market Cap:122.60M
PE:-2.87
High:2.16
Open:2.08
Low:2.05
Close:2.04
52wk High:4.94
52wk Low:1.60
Shares:57.29M
Float Shares:52.60M
Volume Ratio:1.02
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7446
EPS(LYR):0.3900
ROE:-37.21%
ROA:-19.11%
PB:1.28
PE(LYR):5.49

Loading ...

Sep 23, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 17, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Aug 10, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Major Issues Report

8-K - Current report
Jun 22, 2021

Major Issues Report

8-K - Current report
May 19, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2021

Major Issues Report

8-K - Current report
Apr 21, 2021

Major Issues Report

8-K - Current report
Mar 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2021

Major Issues Report

8-K - Current report
Mar 15, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Major Issues Report

8-K - Current report
Dec 03, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 23, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]